βGluCnCs intake for 12 weeks significantly increased the average change in the ApoA1/ApoB ratio in subjects with overweight and low-LDLc levels, but not in those with obesity and high-LDLc levels (Figure 4C). The gene discussed is APOB; the disease is obesity due to melanocortin 4 receptor deficiency.